Over-the-Counter Oral Contraceptive Pills September 27, 2024 Issue Brief Oral contraceptives are the most commonly used method of reversible contraception in the U.S. In July 2023, the FDA approved Opill, the first daily oral contraceptive pill to become available over the counter (OTC) without a doctor’s prescription. This issue brief provides an overview of OTC oral contraceptives and laws and policies related to insurance coverage.
Average Annual Single Premium per Enrolled Employee For Employer-Based Health Insurance September 24, 2024 State Indicator
Average Annual Family Premium per Enrolled Employee For Employer-Based Health Insurance September 24, 2024 State Indicator
Average Annual Employee-Plus-One Premium per Enrolled Employee For Employer-Based Health Insurance September 24, 2024 State Indicator
Average Annual Deductible per Enrolled Employee in Employer-Based Health Insurance for Single and Family Coverage September 24, 2024 State Indicator
How Many Adults with Private Health Insurance Could Use GLP-1 Drugs September 6, 2024 Issue Brief More than two in five (42%) or 57.4 million adults under 65 with private insurance could be eligible under clinical criteria for GLP-1 drugs used to treat people with type 2 diabetes, obesity, or excess weight and weight-related health issues, according to a new KFF analysis. Though only about 3%…
How Narrow or Broad Are ACA Marketplace Physician Networks? August 26, 2024 Report This report examines the share of doctors participating in the provider networks of Qualified Health Plans (QHPs) offered in the individual market in the federal and state Marketplaces in 2021, and how network breadth affected costs for enrollees.
KFF Analysis Finds Physician Networks in ACA Marketplace Plans Vary Widely, and Enrollees Typically Pay More in Premiums to Access Broader Networks August 26, 2024 News Release A KFF analysis of physician networks in the Affordable Care Act’s Marketplace plans finds wide variations in the share of local practicing physicians who participate, with the least costly plans generally having a smaller share of physicians than more expensive plans. The analysis examines the breadth of physician networks listed…
While Medicare Drug Price Negotiations Don’t Apply to Private Insurance, 3.4 Million People with Employer Coverage Take at Least One of the Selected Drugs August 14, 2024 News Release Among the 167 million people with employer-sponsored insurance in 2022, 3.4 million used at least one of the first 10 drugs identified for Medicare price negotiations.
